Bayer Long Term Debt 2010-2024 | BAYRY

Bayer long term debt for the quarter ending September 30, 2024 was $40.325B, a 5.52% increase year-over-year.

  • Bayer long term debt for 2023 was $41.318B, a 16.05% increase from 2022.
  • Bayer long term debt for 2022 was $35.602B, a 17.51% decline from 2021.
  • Bayer long term debt for 2021 was $43.161B, a 13.82% increase from 2020.

Bayer Long Term Debt 2010-2024 | BAYRY

  • Bayer long term debt for 2023 was $41.318B, a 16.05% increase from 2022.
  • Bayer long term debt for 2022 was $35.602B, a 17.51% decline from 2021.
  • Bayer long term debt for 2021 was $43.161B, a 13.82% increase from 2020.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$759.4B
Novo Nordisk (NVO)$387.1B
Johnson & Johnson (JNJ)$342B
AbbVie (ABBV)$309.5B
Merck (MRK)$251.1B
AstraZeneca (AZN)$207.8B
Novartis AG (NVS)$202.5B
Pfizer (PFE)$151.4B
Sanofi (SNY)$123.7B
Innoviva (INVA)$1.1B